Shaanxi Meibang Pharmaceutical Group Co., Ltd. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €105.36M +26.7% €4.39M -36.0% 4.2% -0.041 pp €52.26M -18.4% 49.6% -0.27 pp
    €83.17M -22.8% €6.85M -60.3% 8.2% -0.078 pp €64.07M +128.5% 77.0% +0.51 pp
    €107.80M +7.5% €17.26M +15.4% 16.0% +0.011 pp €28.04M -10,692.4% 26.0% +0.26 pp
    €100.24M +48.2% €14.96M +59.7% 14.9% +0.011 pp -€264.76K -101.6% -0.3% -0.24 pp
    €67.64M +10.2% €9.37M +3.2% 13.8% -0.0094 pp €16.25M -15.8% 24.0% -0.074 pp
    €61.36M +17.6% €9.07M +28.5% 14.8% +0.013 pp €19.30M +213.1% 31.5% +0.20 pp
    €52.18M +3.9% €7.06M -3.1% 13.5% -0.0098 pp €6.17M +10.3% 11.8% +0.0069 pp
    €50.21M €7.28M 14.5% €5.59M 11.1%

    Notifications